IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—2 April

8:16 AM MDT | April 2, 2013 | Deepti Ramesh

Ferro sells pharma business Ferro has completed the sale of its pharmaceuticals business, Pfanstiehl Laboratories, to private equity firm Med Opportunity Partners (Greenwich, CT). Ferro will receive $16.9 million cash and an incentive payment of up to $8 million, payable over 2 years based on the unit's earnings performance. Ferro says it has also retained certain tax benefits with an estimated value of approximately $5 million. Ferro’s pharmaceuticals business posted sales of $24 million and generated a segment income of $2.4 million in 2012. Daiichi...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily newsvv and analysis from the entire global chemical enterprise on chemweek.com
  • Free mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa